May 2026 in “International Journal for Educational Integrity” Contract cheating website traffic in Spain surged during COVID-19 but declined with the rise of AI tools.
September 2025 in “Journal of Medical Internet Research” Expanding telemedicine in Japan reduced healthcare costs without harming health outcomes.
Resident doctors had more facial skin discoloration than medical students during COVID-19.
January 2025 in “International Journal of Trichology” Severe hair loss may increase the risk of dying from COVID-19.
January 2025 in “Lume (Universidade Federal do Rio Grande do Sul)” Hair loss was the most common skin issue among healthcare workers with COVID-19.
September 2024 in “International Journal of Pharmaceutical Quality Assurance” Shirodhara may help improve mental well-being, but more research is needed.
May 2024 in “International journal of medicine and psychology.” Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.
Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.
February 2024 in “PubMed” More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.
January 2023 in “IP International Journal of Comprehensive and Advanced Pharmacology” Ayurvedic Rasayan formulations like Chyawanprash may help manage post-COVID symptoms by boosting immunity.
December 2022 in “Urology Herald” Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.
November 2022 in “Journal of the Endocrine Society” A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.
September 2022 in “JAMC. Journal of Ayub Medical College, Abbotabad, Pakistan/Journal of Ayub Medical College” A boy with a rare skin condition improved quickly after starting zinc supplements.
Icosapent ethyl may help treat long-lasting symptoms after COVID-19.
June 2022 in “Organic communications” Natural compounds, especially Withaferin-A, may help treat post-COVID-19 complications, but some may have side effects.
May 2022 in “Gastroenterology” Supplemental testosterone may lower liver cancer risk in hepatitis C patients.
April 2022 in “Research review”
February 2022 in “International journal of KIU” Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.
January 2022 in “International Journal of Nutrology” Diet and nutrients, including lycopene from tomatoes and hydroquinone from wheat, can help control melasma, a skin condition.
January 2022 in “International Journal of Science and Research (IJSR)” Women with PCOS may be more susceptible to COVID-19 due to hormonal and psychological factors.
December 2021 in “Australasian Journal of Dermatology” Red stripes on nails and hair loss may occur after COVID-19.
December 2021 in “Consilium Medicum” The combined Selencin treatment effectively reduces hair loss and improves hair health after COVID-19.
September 2021 in “Psychoneuroendocrinology” Nurses had higher stress levels during intense phases of the COVID-19 pandemic.
October 2020 in “Проблемы эндокринологии” Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.
September 2020 in “arXiv (Cornell University)” Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.
July 2020 in “Hair transplant forum international” Androgens might play a role in the severity of COVID-19.
January 2021 in “Journal of The European Academy of Dermatology and Venereology” Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.
170 citations
,
September 2020 in “Viruses” Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.
77 citations
,
July 2020 in “European Journal of Clinical Pharmacology” Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.
70 citations
,
July 2020 in “Pharmacological Reports” Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.